APA (7th ed.) Citation

Krämer, A., Losa, F., Gay, L. M., Page, D. R., Foser, S., Mughal, T. I., . . . Osborne, S. (2018). 445TiPComprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy. Annals of Oncology, 29, N.PAG. https://doi.org/10.1093/annonc/mdy279.432

Chicago Style (17th ed.) Citation

Krämer, A., et al. "445TiPComprehensive Profiling and Molecularly Guided Therapy (MGT) for Carcinomas of Unknown Primary (CUP): CUPISCO: A Phase II, Randomised, Multicentre Study Comparing Targeted Therapy or Immunotherapy with Standard Platinum-based Chemotherapy." Annals of Oncology 29 (2018): N.PAG. https://doi.org/10.1093/annonc/mdy279.432.

MLA (9th ed.) Citation

Krämer, A., et al. "445TiPComprehensive Profiling and Molecularly Guided Therapy (MGT) for Carcinomas of Unknown Primary (CUP): CUPISCO: A Phase II, Randomised, Multicentre Study Comparing Targeted Therapy or Immunotherapy with Standard Platinum-based Chemotherapy." Annals of Oncology, vol. 29, 2018, p. N.PAG, https://doi.org/10.1093/annonc/mdy279.432.